logo
Plus   Neg
Share
Email

Gilead Sciences Names Andrew Dickinson CFO - Quick Facts

Gilead Sciences, Inc. (GILD), a research-based biopharmaceutical company, announced the appointment of Andrew Dickinson as Chief Financial Officer, effective November 1. He currently serves as Executive Vice President, Corporate Development and Strategy. Dickinson will retain responsibility for the corporate development and strategy organization.

Andrew Dickinson joined the company in 2016. Prior to this, Dickinson worked for Lazard Frères & Co., where he was Global Co-Head of Healthcare Investment Banking. Prior to Lazard, he was General Counsel and Vice President of Corporate Development at Myogen, Inc.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Polaris Industries Inc. is recalling certain Ranger and General Utility, as well as All-Terrain vehicles citing risks of crash, the U.S. Consumer Product Safety Commission said in a statement. The Medina, Minnesota-based company has called back about 26,730 units of Model Year 2019 - 2020 Ranger XP 1000 & Model Year 2020 General XP 1000 Utility vehicles. Gilead Sciences Inc. (GILD) said Friday that the European Commission has granted conditional marketing authorization for Veklury or remdesivir as a treatment for SARS-CoV-2 infection, the virus that causes COVID-19. FedEx is asking NFL team Washington Redskins to change its name for its racist connotations. The delivery services company, which is a major sponsor for the team, made the suggestion following increasing pressure from its investors amid the ongoing protests against racial injustice and inequality that arose from the killing of African-American George Floyd.
Follow RTT